SE9201529D0 - Monoklonala antikroppar och antigen foer icke-smaacelligt humanlungkarcinom och vissa andra humankarcinom - Google Patents

Monoklonala antikroppar och antigen foer icke-smaacelligt humanlungkarcinom och vissa andra humankarcinom

Info

Publication number
SE9201529D0
SE9201529D0 SE9201529A SE9201529A SE9201529D0 SE 9201529 D0 SE9201529 D0 SE 9201529D0 SE 9201529 A SE9201529 A SE 9201529A SE 9201529 A SE9201529 A SE 9201529A SE 9201529 D0 SE9201529 D0 SE 9201529D0
Authority
SE
Sweden
Prior art keywords
human
certain
carcinomas
cancer
cells
Prior art date
Application number
SE9201529A
Other languages
English (en)
Other versions
SE9201529A0 (sv
Inventor
K E Hellstroem
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of SE9201529D0 publication Critical patent/SE9201529D0/sv
Publication of SE9201529A0 publication Critical patent/SE9201529A0/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9201529A 1986-02-26 1992-05-14 Monoklonala antikroppar och antigen för icke-småcelligt humanlungkarcinom och vissa andra humankarcinom SE9201529A0 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/834,172 US5185432A (en) 1986-02-26 1986-02-26 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas

Publications (2)

Publication Number Publication Date
SE9201529D0 true SE9201529D0 (sv) 1992-05-14
SE9201529A0 SE9201529A0 (sv) 1992-05-14

Family

ID=25266276

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8700805A SE467988B (sv) 1986-02-26 1987-02-25 Monoklonal antikropp med specificitet foer ett 110kd cellyteprotein vid icke smaacelligt humanlungkarcinom
SE9201529A SE9201529A0 (sv) 1986-02-26 1992-05-14 Monoklonala antikroppar och antigen för icke-småcelligt humanlungkarcinom och vissa andra humankarcinom

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8700805A SE467988B (sv) 1986-02-26 1987-02-25 Monoklonal antikropp med specificitet foer ett 110kd cellyteprotein vid icke smaacelligt humanlungkarcinom

Country Status (28)

Country Link
US (1) US5185432A (sv)
JP (1) JPS62220197A (sv)
KR (2) KR900006338B1 (sv)
CN (1) CN87100927A (sv)
AT (1) AT400577B (sv)
AU (1) AU612967B2 (sv)
BE (1) BE1000611A5 (sv)
CA (1) CA1312025C (sv)
CH (1) CH675880A5 (sv)
DD (2) DD266028A5 (sv)
DE (1) DE3705276A1 (sv)
DK (1) DK98187A (sv)
ES (1) ES2004245A6 (sv)
FI (1) FI870764A (sv)
FR (1) FR2596062B1 (sv)
GB (1) GB2186885B (sv)
GR (1) GR870294B (sv)
IE (1) IE60286B1 (sv)
IT (1) IT1203511B (sv)
LU (1) LU86786A1 (sv)
NL (1) NL8700415A (sv)
NO (1) NO174719C (sv)
NZ (1) NZ219338A (sv)
OA (1) OA08485A (sv)
PT (1) PT84370B (sv)
SE (2) SE467988B (sv)
YU (1) YU46189B (sv)
ZA (1) ZA869494B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531301A1 (de) * 1985-09-02 1987-03-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung
JPH0813840B2 (ja) * 1987-03-31 1996-02-14 協和醗酵工業株式会社 抗ヒト肺腺癌単クロ−ン性抗体
US5134075A (en) * 1989-02-17 1992-07-28 Oncogen Limited Partnership Monoclonal antibody to novel antigen associated with human tumors
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
DE69831522T2 (de) 1997-03-03 2006-06-14 Amersham Biosciences Uk Ltd In-situ Zellextraktion und Assay-Verfahren
DE19725133A1 (de) * 1997-06-13 1998-12-17 Micromet Ges Fuer Biomedizinis Nachweis von seltenen Zellen
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
US6117981A (en) * 1999-06-03 2000-09-12 Cytoclonal Pharmaceutics, Inc. Hybridomas for lung cancer marker and monoclonal antibodies thereof
AU7337400A (en) * 1999-09-03 2001-04-10 Human Genome Sciences, Inc. B7-like polynucleotides, polypeptides, and antibodies
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
TWI317285B (en) * 2000-07-28 2009-11-21 Dainippon Sumitomo Pharma Co New use and kit for remedies for cancer
CN101724072B (zh) * 2008-10-27 2013-10-09 谷为岳 一种抗肿瘤的单克隆抗体的序列及应用
GB0916686D0 (en) * 2009-09-23 2009-11-04 Univ Manchester Metropolitan Treatment of cancer
MX345232B (es) 2010-03-04 2017-01-20 Macrogenics Inc Anticuerpos reactivos con b7-h3, fragmentos inmunologicamente activos de los mismos y sus usos.
US8802091B2 (en) 2010-03-04 2014-08-12 Macrogenics, Inc. Antibodies reactive with B7-H3 and uses thereof
US9696320B2 (en) * 2010-09-17 2017-07-04 National Institute Of Advanced Industrial Science And Technology Lung cancer differential marker
CN102391992B (zh) * 2011-11-03 2012-08-29 潘世扬 抗人非小细胞肺癌单克隆抗体及其应用
WO2017180813A1 (en) 2016-04-15 2017-10-19 Macrogenics, Inc. Novel b7-h3 binding molecules, antibody drug conjugates thereof and methods of use thereof
CN111662371B (zh) * 2020-04-30 2023-07-04 美康生物科技股份有限公司 细胞角蛋白19片段抗原及其制备方法和应用
CN112300284B (zh) * 2020-12-29 2021-04-06 慈达(广州)生物技术有限公司 核酸筛选结合抗体检测用于癌症检测中的用途及其制备的试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer
ZA858371B (en) * 1984-11-02 1987-03-25 Oncogen Monoclonal antibodies for human non-small cell lung carcinomas
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies

Also Published As

Publication number Publication date
GB2186885B (en) 1990-10-03
GR870294B (en) 1987-06-30
BE1000611A5 (fr) 1989-02-21
YU46189B (sh) 1993-05-28
ES2004245A6 (es) 1988-12-16
FR2596062A1 (fr) 1987-09-25
NO870770L (no) 1987-08-27
CN87100927A (zh) 1988-10-05
IE60286B1 (en) 1994-06-29
KR880010438A (ko) 1988-10-08
PT84370A (en) 1987-03-01
CH675880A5 (sv) 1990-11-15
NZ219338A (en) 1991-11-26
ATA43587A (de) 1995-06-15
NO174719B (no) 1994-03-14
FI870764A (fi) 1987-08-27
AU6927287A (en) 1987-08-27
SE8700805L (sv) 1987-10-22
ZA869494B (en) 1987-10-28
KR870008026A (ko) 1987-09-23
NO870770D0 (no) 1987-02-25
DK98187A (da) 1987-08-27
OA08485A (fr) 1988-07-29
SE9201529A0 (sv) 1992-05-14
DD266028A5 (de) 1989-03-22
IE870487L (en) 1987-08-26
FI870764A0 (fi) 1987-02-23
DK98187D0 (da) 1987-02-25
PT84370B (pt) 1989-11-10
IT1203511B (it) 1989-02-15
JPS62220197A (ja) 1987-09-28
FR2596062B1 (fr) 1990-06-08
KR900006338B1 (ko) 1990-08-28
CA1312025C (en) 1992-12-29
IT8719491A0 (it) 1987-02-25
LU86786A1 (fr) 1987-09-15
US5185432A (en) 1993-02-09
AU612967B2 (en) 1991-07-25
AT400577B (de) 1996-01-25
SE8700805D0 (sv) 1987-02-25
NO174719C (no) 1994-06-22
NL8700415A (nl) 1987-09-16
GB2186885A (en) 1987-08-26
GB8703700D0 (en) 1987-03-25
DE3705276A1 (de) 1987-08-27
YU25787A (en) 1990-12-31
DD276165A5 (de) 1990-02-14
SE467988B (sv) 1992-10-12

Similar Documents

Publication Publication Date Title
SE9201529D0 (sv) Monoklonala antikroppar och antigen foer icke-smaacelligt humanlungkarcinom och vissa andra humankarcinom
NZ232554A (en) 100,000 dalton tumour cell glycoprotein antigen (l45), monoclonal antibodies thereto and medicaments
ATE77701T1 (de) Monoklonale antikoerper und antigen fuer menschliche lungenkarzinome vom nichtkleinen zellentyp.
GB2182949A (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
ATE91132T1 (de) Monoklonale antikoerper fuer humane lungenkarzinome des ''nicht-kleine-zellen''-typs.
Shitara et al. Glycoproteins Distinguishing Non-Small Cell From Small Cell Human Lung Car-cinoma Recognized by Monoclonal An-tibody 43-9F. Pettijohn, DE, Stranahan, PL, Due
Brain et al. A Comparison of Clonogenic and Radionuclide Uptake Assays for Deter-mining the Radiation Response of Human Small-Cell Lung Cancer Xenografts and Cell Lines.
NO914094L (no) Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9201529-6

Format of ref document f/p: F